Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis

J M Middeldorp, P Herbrink

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The molecular specificity of the antibody response against Epstein-Barr Virus (EBV) is studied in patients with acute primary EBV-infection, i.e. infectious mononucleosis syndrome. Using the immunoblot technique both IgM and IgG antibody responses are studied in sera obtained serially until week 20 after onset of symptoms. Healthy seropositive blood donors are used as control. Antigens are prepared from virus producer cell lines B95-8, P3HR1 and HH514-c16 (a superinducible derivative of P3HR1), induced for the expression of early antigens (EA) or viral capsid antigens (VCA) and from the EBV-negative cell lines BJAB and RAMOS. The 'WC'-serum, described by Edson et al. (J. Immunol. 130, 1983) is used to characterize EA- and VCA-specific polypeptides and to define their subcellular location. The immunoblot studies reveal an enormous diversity in EBV-specific polypeptides recognised by different individual patients, both for IgM and IgG. In addition, these patterns were markedly different from those found with control blood donor sera. The latter predominantly recognised bands at 72 kDa (EBNA) and 41 and 18 kDa respectively (both VCA components). Despite the great individual variation observed, EA-specific polypeptides at 138 kDa and at 45-52 kDa were recognised by both IgM and IgG antibodies in first serum samples of all patients tested.

Original languageEnglish
Pages (from-to)133-46
Number of pages14
JournalJournal of Virological Methods
Volume21
Issue number1-4
Publication statusPublished - Sep 1988

Cite this

@article{7c60031b1be44a509dc573cede61989c,
title = "Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis",
abstract = "The molecular specificity of the antibody response against Epstein-Barr Virus (EBV) is studied in patients with acute primary EBV-infection, i.e. infectious mononucleosis syndrome. Using the immunoblot technique both IgM and IgG antibody responses are studied in sera obtained serially until week 20 after onset of symptoms. Healthy seropositive blood donors are used as control. Antigens are prepared from virus producer cell lines B95-8, P3HR1 and HH514-c16 (a superinducible derivative of P3HR1), induced for the expression of early antigens (EA) or viral capsid antigens (VCA) and from the EBV-negative cell lines BJAB and RAMOS. The 'WC'-serum, described by Edson et al. (J. Immunol. 130, 1983) is used to characterize EA- and VCA-specific polypeptides and to define their subcellular location. The immunoblot studies reveal an enormous diversity in EBV-specific polypeptides recognised by different individual patients, both for IgM and IgG. In addition, these patterns were markedly different from those found with control blood donor sera. The latter predominantly recognised bands at 72 kDa (EBNA) and 41 and 18 kDa respectively (both VCA components). Despite the great individual variation observed, EA-specific polypeptides at 138 kDa and at 45-52 kDa were recognised by both IgM and IgG antibodies in first serum samples of all patients tested.",
keywords = "Acute Disease, Antibodies, Viral, Antibody Specificity, Antigens, Viral, Capsid Proteins, Cell Line, Electrophoresis, Polyacrylamide Gel, Fluorescent Antibody Technique, Herpesvirus 4, Human, Humans, Immunoblotting, Immunoglobulin G, Immunoglobulin M, Infectious Mononucleosis, Journal Article",
author = "Middeldorp, {J M} and P Herbrink",
year = "1988",
month = "9",
language = "English",
volume = "21",
pages = "133--46",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",
number = "1-4",

}

Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. / Middeldorp, J M; Herbrink, P.

In: Journal of Virological Methods, Vol. 21, No. 1-4, 09.1988, p. 133-46.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis

AU - Middeldorp, J M

AU - Herbrink, P

PY - 1988/9

Y1 - 1988/9

N2 - The molecular specificity of the antibody response against Epstein-Barr Virus (EBV) is studied in patients with acute primary EBV-infection, i.e. infectious mononucleosis syndrome. Using the immunoblot technique both IgM and IgG antibody responses are studied in sera obtained serially until week 20 after onset of symptoms. Healthy seropositive blood donors are used as control. Antigens are prepared from virus producer cell lines B95-8, P3HR1 and HH514-c16 (a superinducible derivative of P3HR1), induced for the expression of early antigens (EA) or viral capsid antigens (VCA) and from the EBV-negative cell lines BJAB and RAMOS. The 'WC'-serum, described by Edson et al. (J. Immunol. 130, 1983) is used to characterize EA- and VCA-specific polypeptides and to define their subcellular location. The immunoblot studies reveal an enormous diversity in EBV-specific polypeptides recognised by different individual patients, both for IgM and IgG. In addition, these patterns were markedly different from those found with control blood donor sera. The latter predominantly recognised bands at 72 kDa (EBNA) and 41 and 18 kDa respectively (both VCA components). Despite the great individual variation observed, EA-specific polypeptides at 138 kDa and at 45-52 kDa were recognised by both IgM and IgG antibodies in first serum samples of all patients tested.

AB - The molecular specificity of the antibody response against Epstein-Barr Virus (EBV) is studied in patients with acute primary EBV-infection, i.e. infectious mononucleosis syndrome. Using the immunoblot technique both IgM and IgG antibody responses are studied in sera obtained serially until week 20 after onset of symptoms. Healthy seropositive blood donors are used as control. Antigens are prepared from virus producer cell lines B95-8, P3HR1 and HH514-c16 (a superinducible derivative of P3HR1), induced for the expression of early antigens (EA) or viral capsid antigens (VCA) and from the EBV-negative cell lines BJAB and RAMOS. The 'WC'-serum, described by Edson et al. (J. Immunol. 130, 1983) is used to characterize EA- and VCA-specific polypeptides and to define their subcellular location. The immunoblot studies reveal an enormous diversity in EBV-specific polypeptides recognised by different individual patients, both for IgM and IgG. In addition, these patterns were markedly different from those found with control blood donor sera. The latter predominantly recognised bands at 72 kDa (EBNA) and 41 and 18 kDa respectively (both VCA components). Despite the great individual variation observed, EA-specific polypeptides at 138 kDa and at 45-52 kDa were recognised by both IgM and IgG antibodies in first serum samples of all patients tested.

KW - Acute Disease

KW - Antibodies, Viral

KW - Antibody Specificity

KW - Antigens, Viral

KW - Capsid Proteins

KW - Cell Line

KW - Electrophoresis, Polyacrylamide Gel

KW - Fluorescent Antibody Technique

KW - Herpesvirus 4, Human

KW - Humans

KW - Immunoblotting

KW - Immunoglobulin G

KW - Immunoglobulin M

KW - Infectious Mononucleosis

KW - Journal Article

M3 - Article

VL - 21

SP - 133

EP - 146

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

IS - 1-4

ER -